Zoetis, Inc. (ZTS)
77.00
-0.10
(-0.13%)
USD |
NYSE |
Sep 01, 12:00
Zoetis Cash from Operations (TTM) : 2.887B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.887B |
| March 31, 2026 | 2.837B |
| December 31, 2025 | 2.951B |
| September 30, 2025 | 2.963B |
| June 30, 2025 | 2.976B |
| March 31, 2025 | 2.873B |
| December 31, 2024 | 2.953B |
| September 30, 2024 | 2.945B |
| June 30, 2024 | 2.718B |
| March 31, 2024 | 2.399B |
| December 31, 2023 | 2.353B |
| September 30, 2023 | 2.197B |
| June 30, 2023 | 1.999B |
| March 31, 2023 | 2.152B |
| December 31, 2022 | 1.912B |
| September 30, 2022 | 1.85B |
| June 30, 2022 | 1.977B |
| March 31, 2022 | 2.122B |
| December 31, 2021 | 2.213B |
| September 30, 2021 | 2.252B |
| June 30, 2021 | 2.161B |
| March 31, 2021 | 2.118B |
| December 31, 2020 | 2.126B |
| September 30, 2020 | 1.99B |
| June 30, 2020 | 1.934B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.814B |
| December 31, 2019 | 1.795B |
| September 30, 2019 | 1.797B |
| June 30, 2019 | 1.841B |
| March 31, 2019 | 1.79B |
| December 31, 2018 | 1.79B |
| September 30, 2018 | 1.814B |
| June 30, 2018 | 1.703B |
| March 31, 2018 | 1.616B |
| December 31, 2017 | 1.346B |
| September 30, 2017 | 1.024B |
| June 30, 2017 | 824.00M |
| March 31, 2017 | 781.00M |
| December 31, 2016 | 713.00M |
| September 30, 2016 | 705.00M |
| June 30, 2016 | 670.00M |
| March 31, 2016 | 655.00M |
| December 31, 2015 | 664.00M |
| September 30, 2015 | 773.00M |
| June 30, 2015 | 672.00M |
| March 31, 2015 | 709.00M |
| December 31, 2014 | 626.00M |
| September 30, 2014 | 537.00M |
| June 30, 2014 | 548.00M |
| March 31, 2014 | 377.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Elanco Animal Health, Inc. | 617.00M |
| Merck & Co., Inc. | 19.97B |
| Phibro Animal Health Corp. | 68.95M |
| Pfizer Inc. | 13.40B |
| Boston Scientific Corp. | 4.529B |